February 1, 2022
1 min read

US FDA okays Moderna’s Covid-19 jab for adults

Spikevax meets the FDA’s rigorous standards for safety, effectiveness and manufacturing quality required for approval…reports Asian Lite News

Moderna’s Covid-19 vaccine has received full approval from the US Food and Drug Administration (FDA).

The vaccine, named Spikevax, is approved for use in people ages 18 and older, Xinhua news agency reported.

Spikevax meets the FDA’s rigorous standards for safety, effectiveness and manufacturing quality required for approval, said the agency in a statement.

“While millions of people have already safely received Covid-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated,” said Acting FDA Commissioner Janet Woodcock.

“Today’s milestone puts us one step closer to altering the course of this pandemic in the US,” she said.

Moderna’s Covid-19 vaccine is the second one in the US to receive full approval from the FDA. Pfizer’s Covid-19 vaccine, Comirnaty, was fully approved for use in people ages 16 and older in August 2021.



Moderna’s Covid-19 vaccine has been available under the FDA’s emergency use authorization for individuals 18 years of age and older since December 18, 2020.

Moderna had earlier began clinical trials of a booster dose of a vaccine designed specifically to combat the Omicron variant of COVID-19.

CNN reported that the trials will involve a total of 600 adults, which will take place at up to 24 sites in the US. Some participants will have already received two doses of Moderna’s vaccine, and some will have received a booster shot.

“We are reassured by the antibody persistence against Omicron at six months after the currently authorized 50 mg booster of mRNA-1273. Nonetheless, given the long-term threat demonstrated by Omicron’s immune escape, we are advancing our Omicron-specific variant vaccine booster candidate and we are pleased to begin this part of our Phase 2 study,” CNN citing CEO Stephane Bancel’s statement reported.

“We are also evaluating whether to include this Omicron-specific candidate in our multivalent booster program,” it added.

ALSO READ: US Pentagon chief, Amir of Qatar hold talks on Afghanistan

Previous Story

Third-wave fear on ‘CLOTH MASK’

Next Story

US to impose sanctions on Putin’s aides

Latest from -Top News

Words Won’t Stop China, Quad Must Deliver

 If the Quad aims to counterbalance China’s growing influence, it must expand its focus beyond the maritime domain and address the continental dynamics of the Indo-Pacific…writes Imran Khurshid Despite early concerns that

India Stays Neutral on Dalai Lama Succession

As exiled Tibetan spiritual leader approaches his 90th birthday, he asserted on Wednesday that there will be the 15th reincarnation…reports Asian Lite News Responding to the Dalai Lama’s recent remarks, India on

USAID cut could kill 14 million more deaths

Human rights advocates and global health experts have expressed alarm at the speed and scale of the cuts…reports Asian Lite News A new study published in The Lancet has warned that ongoing

Trump goes nuclear on Mamdani

Mamdani, a 33-year-old democratic socialist and son of Indian-Ugandan immigrants, secured a surprise victory over former governor Andrew Cuomo in the Democratic primary.;…reports Asian Lite News President Donald Trump has intensified his

G42 AI tool boosts procurement by 40%

Abu Dhabi’s tech giant leads the charge in AI-driven operational transformation with (In)Business Procurement platform. Abu Dhabi-based global technology powerhouse G42 has taken a major leap in enterprise digital transformation with the
Go toTop

Don't Miss

North Korea warns US of powerful response

North Korea has ramped up its weapons demonstrations to a

US House passes $1.5 trillion spending package

The bill also provides $13.6 billion in supplemental funding to